(OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the first patient enrolled in a Phase I dose ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

A cell tower located on the Huntridge Theater's property has caused significant delays in the restoration of the historic Las ...

“A cell type is a group of cells that are similar to each other and distinct from other groups of cells,” offers ...

If you are willing to hire a lawyer and spend many thousands of dollars to fight your apartment complex, and if you are ...

This school year, many of the nation's adolescents and teens are sitting in class without the device that can sometimes feel ...

Multi-year agreement focuses on the manufacture of multiple CAR-Treg product candidates for Phase 1/2 clinical studies Partnership builds on long-term relationship to provide Quell with additional ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...

Harnessing the body's B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern ...

A team of SAHMRI scientists has discovered a completely new type of cell that has the potential to enhance the future of ...

Teen spent roughly an hour gasping for breath, complaining of pain from burning chemicals on his body. Recurring misuse of ...

Researchers at Johns Hopkins examined human bioengineered heart tissues sent to the International Space Station. They found ...